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Background: Lumagel, a reverse thermosensitive polymer (RTP), provides targeted flow interruption to
the kidney by reversibly plugging segmental branches of the renal artery, allowing blood-free partial
nephrectomy. Extending this technology to the liver requires the development of techniques for temporary
occlusion of the hepatic artery and selected portal vein branches.
Methods: A three-phased, 15 swine study was performed to determine feasibility, techniques and
survival implications of using Lumagel for occlusion of inflow vessels to targeted portions of the liver.
Lumagel was delivered using angiographic techniques to sites determined by pre-operative 3-D vascular
reconstructions of arterial and venous branches. During resection, the targeted liver mass was resected
without vascular clamping. Three survival swine were sacrificed at 3 weeks; the remainder at 6 weeks for
pathological studies.
Results: Six animals (100%) survived, with normal growth, blood tests and no adverse events. Three left
lateral lobe resections encountered no bleeding during resection; one right median resection bled; two
control animals bled significantly. Pre-terminal angiography and autopsy showed no local pathology and
no remote organ damage.
Conclusions: Targeted flow interruption to the left lateral lobe of the swine liver is feasible and allows
resection without bleeding, toxicity or pathological sequelae. Targeting the remaining liver will require
more elaborate plug deposition owing to the extensive collateral venous network.
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Introduction
Liver resection is a surgical innovation that has been used for the
cure of primary and secondary tumours or to provide a viable
graft for live donor liver transplantation.1,2 More recently, laparo-
scopic liver resection has been developed with the goal to reduce
patient morbidity but has the potential drawback of uncontrolled
haemorrhage if technical difficulties are encountered.3,4
Lumagel™ is a clear, colourless thermoplastic polymer that is
liquid at room temperature that reversibly forms a temporary
gel-plug at body temperature and upon intraluminal injection
into an artery or vein results in temporary inflow control.5,6 The
gel plug dissolves spontaneously over time, typically between 30
and 60 min, or may be rapidly dissolved over 2 to 5 min with a
cold saline infusion. Lumagel has no detectable effect on the arte-
rial wall or on the coagulation cascade. The apparent change of
state in Lumagel from liquid to gel is caused by a sudden increase
in viscosity over a fraction of a degree at about 20°C. This occurs
because a change in the molecular configuration exposes hydro-
gen bonds at the higher temperature, causing proximate
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molecules to attract and align. As this alignment is concentration
dependent, a threshold concentration of about 15% (W/V) is
required for a viscosity change to occur. The viscosity change is
strictly a physical reaction and is completely reversible with
cooling which restores the low viscosity state, dissolving the plug
into the surrounding flowing blood. Once dissolved in blood, the
concentration threshold for a viscosity increase is not possible
assuring that no further gel will form. However, in some cases,
cooling plugs greater than about 7 mm in diameter may allow
fragments to break away from the main plug travelling down-
stream causing small emboli that exist for up to 20 min before
spontaneous dissolution. No evidence of harm from these frag-
ments has been found in any animal experiments, or in any
human use of a closely related product, LeGoo, which is a similar
reverse thermosensitive polymer (RTP) without contrast agent,
and has been studied in human off-pump coronary bypass.7 Once
dissolved in the blood, Lumagel is eliminated unchanged in the
urine and bile.
The purpose of the present study was to determine the feasi-
bility of temporary hepatic vasculature occlusion for relatively
bloodless hepatic resection and to develop techniques of inflow
control of hepatic artery and targeted portal vein branches with
Lumagel and to determine safety in a surviving swine model.
General considerations in the use of Lumagel for
bloodless liver resection
Lumagel is a RTP consisting of a mixture of highly fractionated
Poloxamer 407 (BASF, Inc., Florham Park, NJ, USA) and Iohexol,
a non-ionic iodinated vascular contrast agent (30%) in an
aqueous solution. At room temperature, Lumagel is a liquid and
has a viscosity similar to water whereas at body temperature, its
viscosity increases dramatically to approximately 750 000 centi-
poise, conferring on Lumagel the ‘look and feel’ of a solid gel. This
physical change takes place over a fraction of a degree and is
rapidly reversible with cooling. Without cooling, Lumagel will
dissolve spontaneously in times determined by the original
injected mass, but typically in about 30 to 45 min. When injected
quickly into the lumen of an artery or vein, the sudden increase in
viscosity effectively forms a plug which stops blood flow. This plug
is radio-opaque allowing accurate deployment of Lumagel under
real-time fluoroscopic visualization. The viscosity of Lumagel at
room temperature requires a hand-held power injector which
allows control of the injection volume of approximately 0.02 ml
up to 20 ml. As no commercially available injectors were available,
prototype injectors were developed for these experiments. The
power injectors are capable of generating pressures up to 1000
PSI, required for the injection of Lumagel through various-sized
angiographic catheters.
Materials and methods
The study was conducted in three phases: Feasibility, Acute and
Chronic Survival animal experiments. (Table 1). Success in each
phase was required before progressing to the next. All experimen-
tal protocols were approved by the Institutional Animal Care and
Utilization Committees (IACUC) at the Lahey Clinic for the acute
experiments, and the Cummings School of Veterinary Medicine at
Tufts University for the survival experiments.
Feasibility study
The purpose of the earliest experiments was to determine whether
flow interruption to a portion of the liver is possible, whether such
occlusion would be stable for at least 30 min and whether it is
reversible. The hepatic artery was approached by a retrograde
femoral technique, whereas the portal venous branches were
approached using Seldinger catheterization of the superior
mesenteric vein. Catheterization of specific branches of the
hepatic artery was performed in the first three experiments, but
abandoned in favour of simply occluding the main stem of the
hepatic artery or the celiac axis, both because of ease and fre-
quency of collateral branches which required interruption by
plugging the main hepatic artery. The final morphology of the
plug, in either the hepatic artery or the portal vein, was deter-
mined by its real-time appearance on fluoroscopy. Previous
in vitro experiments suggested that a stable plug required a length/
diameter (L/D) ratio of 10, but the anatomy of the pig allowed this
in only the portal venous branch to the left lateral lobe: in other
branches it was usually necessary to settle for an L/D of 5 or less,
which provided total venous occlusion when the vein was some-
what distended with additional Lumagel. The volume of Lumagel
for portal venous branch occlusion was between 10 and 20 ml,
compared with less than 1 ml required for the hepatic artery
occlusion.
Technical phase: acute animal experiments
The purpose of this phase was to determine whether plug depo-
sition in the hepatic artery and the portal venous branches is
reliable and reproducible with a predictable flow interruption
lasting up to 30 min. In addition, it was necessary to determine
whether flow restoration is also reliable and reproducible. Thirty
minutes of flow interruption was chosen as this is sufficient to
perform a blood-free liver resection and to control any visibly
transected vessel. During this phase, the radiological techniques
were standardized as described in the following section.
Interventional radiographical techniques
Hepatic artery flow interruption
After induction of general anaesthesia and intubation, a 7F
femoral arterial sheath was placed. This was achieved using both
open and percutaneous techniques. In the feasibility phase, we
determined that occlusion of individual hepatic arterial branches
was possible, but required the use of microcatheters and consid-
erable time. For the final protocol, we therefore elected to occlude
either the common hepatic artery or, if there were considerable
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collateral circulation, the entire celiac axis was interrupted. There-
fore, the entire arterial supply to the liver was interrupted for
approximately 30 min.
A 4F catheter was introduced, over a guide wire to the origin of
the hepatic artery and an angiogram obtained. Lumagel, which is
radio-opaque, was then injected under direct fluoroscopic
control. The plug was observed in real time to be entering the
lumen of the hepatic artery.When the plug obtained a length of 5
to 10 times the diameter, the injection was stopped and a repeat
arteriogram obtained.
Segmental portal venous flow interruption
After implantation of the femoral sheath but before hepatic artery
occlusion, a midline laparotomy was performed. The superior
mesenteric vein, or an appropriate large mesenteric vein, was
located in the root of the mesentery and a guide wire introduced.
A 7F vascular sheath was introduced via the superior mesenteric
vein (SMV) into the portal vein and a venogram obtained. This
was compared with the 3-D venogram (Fig. 1) and the preselected
segmental or sub-segmental branches for occlusion were identi-
fied. A selective angiographic catheter was then introduced over a
guide wire and an occlusive Lumagel plug was generated by injec-
tion under fluoroscopy (Fig. 2). A repeat venogram was per-
formed confirming flow interruption to the desired region of the
liver.
Plug location
To obtain temporary inflow control of the targeted portion of the
liver, both the arterial and the portal venous branches of those
segments must be plugged. To aid in segment targeting, pre-
operative 3-D renderings using software-assisted computed
tomography (CT)8 angiographic reconstruction of the portal
venous and the hepatic arterial systems were used (Fig. 1).
Initially, highly selected branches of both the hepatic artery and
the portal vein were plugged, but it became apparent that selecting
branches of the hepatic artery was lengthy and unwarranted.
Therefore, the technique was modified to plug the common
hepatic artery as this was technically easier and achieved excellent
results. Portal vein branches were continued to be targeted as
occlusion of the main portal vein required more product and was
less desirable for selective resection.
Plug morphology
C-arm fluoroscopy and standard angiographic catheters were
used to locate targeted vessels. The site for portal venous occlusion
Table 1 Study design and outcome
Phase No. of
Animals
Purpose Outcome
1 Feasibility 4 To determine whether it is possible to interrupt
flow to a portion of the liver
Complete flow interruption requires occlusion of the hepatic
artery and a targeted branch of the portal vein (Fig. 2)
2 Acute
experiments
5 To determine whether a plug may be reproduced
without fail
Yes – in both the hepatic artery and the left lateral branch
of the portal vein
To determine whether the plug can last for
30 min
Yes – it will change and slowly dissolve. The length/
diameter ratio should be 10
To determine if hepatic resection can be
performed without blood loss and without the
need for other hemostatic measures
Essentially no measureable bleeding and no need for
haemostatic measures during resection (Fig. 3)
To determine if flow can be restored reliably on
completion of the hepatic resection
Irrigation of the hepatic artery with iced saline rapidly
restores flow. Irrigation of portal venous plug rapidly
restores flow but leaves small plug fragments which
dissolve over 20 to 30 min
3 Survival
experiments
6 Define adverse events associated with the use of
Lumagel for Liver Resection.
None seen with use in left lateral lobe. Right lobe bled
significantly
Define adverse events which may occur when
the portal venous plug is not actively dissolved
but allowed to dissolve spontaneously.
No adverse events were evident. Liver enzymes did not
change. No pathology seen at autopsy
Define angiographic changes at the site of
plugging 3 and 6 weeks after plug dissolution.
Normal angiograms at exact site of previous plug
deposition, in both the hepatic artery and the portal
venous branch
Define pathological changes at the site of
plugging 3 and 6 weeks after plug dissolution.
No pathology in either the hepatic artery or portal venous
branch (Fig. 4)
Define pathological changes in remote organs
associated with the use of Lumagel.
Gross and microscopic appearance is unremarkable
Compare all above outcomes with control
animals which underwent a comparable liver
resection without the use of Lumagel.
No haemostasis required during resection with the use of
Lumagel; resection very rapid and easy; blood loss
during resection was negligible in the left lateral lobe
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and the growth andmorphology of the plug was monitored under
fluoroscopy. The high pressure of the hepatic arterial system
required a plug of length/diameter ratio of 5 to 10 to achieve
adequate inflow control withminimal distention of the vessel. The
increased distensability of the portal vein required a larger volume
of Lumagel to cause 15 to 25% distension before inflow control
was achieved but the low pressure allowed for a lower length/
diameter (L/D) ratio.
The morphology of the plug is readily seen under fluoroscopy
guidance, and a hand-held injector allows fine control down
to volumes as low as 0.02 ml. However, the final morphology
of the plug is dependent upon the local vascular anatomy
and when the desired L/D of 10 is not attainable the plug
is allowed to grow into the origin of a branching vessel
thereby conferring increased stability and compensating for a
low L/D.
Three-dimensional imaging of the hepatic circulation
Three-dimensional vascular imaging was obtained by synthesiz-
ing electronic data gathered during conventional CT scanning,
using highly specialized clinical software (HepaVision™ and
InterventionPlanner™; Mevis, Bremen, Germany) (Fig. 1). All
animals were anesthetized according to procedures in place at
the Cummings School of Veterinary medicine at Tufts University
in preparation for CT scanning. They were then recovered and
maintained for about 1 week before undergoing hepatic resec-
tion experiments. A CT angiography was performed after the
administration of 120 ml iodine contrast intravenously to
display the hepatic arterial anatomy. For display of the portal
venous anatomy the second CT image was set to 40 s after the
arterial phase. HepaVision and an InterventionPlanner were
used to accomplish the volumetric analysis of the liver and the
assessment of segmental arterial and portal venous blood supply.
(b) (a) 
Figure 1 Three-dimensional reconstruction of the portal venous circulation of a typical swine. Note the single dominant portal vein. Each
colour represents a different segment
B A 
Figure 2 Digital subtraction portal venography before and after deposition of the Lumagel Plug. Gel plugs can be programmed to dissolve
spontaneously or dissolved with a cold saline injection
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Phase 2 animal experiments
The purpose of these animal experiments was to prove that a
reliable, reproducible technique for targeted flow interruption
allows hepatic resection without blood less. As the left lateral
portal vein branch is a constant, relatively long branch, it was
selected for Lumagel Plug deposition, along with the hepatic
artery. In all these cases, left lateral hepatic resection of a liver
wedge between 10 and 12 cm was performed. Blood loss was
consistently less than sufficient to stain one surgical gauze, and
required no haemostatic measures during resection. One addi-
tional acute experiment was performed when it was discovered
that sterilization of the Lumagel using e-beam had a dramatic
effect on the viscosity, lowering it by 30%. This animal demon-
strated plug stability that was similar in all aspects with the more
viscous form of the polymer, but this lower viscosity plug was
more readily removed with cold saline irrigation.
Phase 3 animal experiments: survival study
Six Yorkshire swine (40–50 kg) were used for 3- and 6-week sur-
vival studies. Anaesthesia was induced according to protocols in
place at the Tufts Cummings School of Veterinary Medicine, after
which the animal was intubated and placed recumbent on the
operating table. The right internal jugular vein was used for a large
bore catheter should rapid infusion become necessary. The
hepatic artery and portal venous branches were accessed as
described above. The abdomen was entered through a midline
incision. Blood pressure and electrocardiography (EKG) monitor-
ing were performed. The six surviving pigs were divided into two
groups of three: the first group surviving for 6 weeks and the
second for 3 weeks. One animal in each group served as a control,
undergoing standard liver resection using the finger fracture tech-
nique. (An attempt at the Pringle manoeuver resulted in the
animal becoming severely hypotensive, related to the enormous
intestinal circulation in the swine.) Blood tests were performed at
1 week and at sacrifice. In two pigs, no attempt at dissolving the
portal plug was made, as the plugs will disappear spontaneously
shortly after the requisite 30 min and return of flow precedes the
complete radiological disappearance of all traces of the Lumagel
plug in the venous system. In all but one animal, the left lateral
lobe was resected (Fig. 3); in the exception we elected to attempt
resection of the right anterior inferior segment. With all liver
resections, large venous branches were ligated with fine silk liga-
tures. Lumagel could be seen in the vessels at the time of ligation.
Immediately before to sacrifice, animals underwent a repeat
angiography, primarily to document any changes at the exact sites
of previous plug deployment in the hepatic artery and the portal
venous circulation. Complete necropsy was obtained on all
animals and microscopic examination of the liver, heart, lungs,
kidney and spleen was performed. Sectioning the liver was focused
on including the exact sites in the arterial and venous branches
which had previously undergone plugging. These vessels under-
went staining with hematoxylin and eosin (H&E), reticular, Peri-
odic acid-Schiff (PAS), trichrome and Jones stains.
Results
Results of all phases are summarized in Table 1. The feasibility
experiments were used to test specific developments or changes in
the Lumagel system, resulting in the techniques described above.
The acute study, Phase 2, demonstrated reproducible targeted
blood flow interruption using the same procedure in all animals
and was used to standardize the angiographic techniques as
described in the methods section.
The Survival Study (Phase 3) consisted of six pigs. All animals
survived surgery. The first animal was a control in which a Pringle
manoeuver to control blood loss was attempted. However, this
animal became hypotensive and tachycardic within 3 min of the
obstruction of portal flow. The Pringle manoeuver was aban-
doned, and the blood pressure gradually came back to baseline. A
routine liver resection was then completed using the finger frac-
ture technique and electrocautery. Large venous branches were
ligated with fine silk ligatures. One animal in which the right
Figure 3 Liver resection without vascular clamps. Arrow shows Lumagel in the orifice of the cut portal vein branch
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anterior inferior hepatic lobe resection was attempted, error
in locating the proper territory occluded with Lumagel resulted
in profuse bleeding and a rapid resection was carried using
suture ligation and the finger fracture technique to control the
haemorrhage.
All animals gained weight normally, about 10 pounds per week.
One animal which received Lumagel had a wound dehiscence 2
days post-operatively requiring emergency repair. All other
wounds healed normally, although two animals had small areas of
fat necrosis with sterile abscesses in the subcutaneous tissue.
Blood work revealed no abnormalities over the 3- and 6-week
durations. The pre-terminal angiograms showed no thrombus, no
arterial or venous wall changes and no aneurysm formation at the
site of previous vascular plug deposition. No pulmonary emboli
were observed.
Gross necropsy also showed no significant abnormalities. The
first control pig in which a Pringle manoeuver was attempted
showed considerable scarring and bowel adhesion around the
hilum of the liver.While there was no bowel distension or sugges-
tion of an obstruction, this was the only animal with a large
distended gall bladder but microscopy failed to disclose any
underlying pathology. Three animals had some pulmonary con-
gestion and peribronchial inflammation. One was a non-Lumagel
animal and while a second was the animal which had undergone
excision of a section of the right half of the median lobe.
No pathological vascular changes were seen at the sites of plug
deposition (Fig. 4). Of interest, in the two animals in which there
was no attempt to remove the venous plug, no gross or micro-
scopic changes were seen, indicating the absence of local tissue
damage from the plug. As the hepatic arterial flow had been
re-established in these animals, it seems to be sufficient, and the
time for disappearance of the venous plug is short enough that
no liver damage occurred. In one of these animals, lymphoid
aggregates were noted in the portal region and the parenchyma,
but not in the resection margin downstream of the plug, where it
might have raised suspicion of a toxic reaction. Figure 4 shows a
section of the liver and portal vein branch obtained from the exact
site of a previous venous plug. The liver architecture is completely
normal, and the venous branch shows no endothelial hyperplasia,
no thrombus or even a fragment of thrombotic tissue suggesting
previous vascular wall damage related to the Lumagel. Granulo-
mas from suturing the liver capsule were seen at the suture site,
but nowhere else in the liver. Downstream of the Lumagel plug, all
tissue was stained with Jones , H&E, PAS, rrichrome at reticular
stains. No histological changes were seen in 12 to 15 blocks taken
from each liver.
The lung, heart, spleen and kidney underwent gross and repre-
sentative microscopic examination. Other than the pulmonary
congestion described above, there were no histological abnormali-
ties in any organs. The lungs showed no evidence of pulmonary
emboli.
Discussion
Increasing the safety of a liver resection has been an important
goal, especially since the advent of living donor and laparoscopic
hepatectomy. Lumagel presents a novel means of temporarily
interrupting blood flow without traumatizing blood vessels.
This may be especially important during minimally invasive
laparoscopic cases, where inflow control can be difficult to
achieve.
Lumagel is a purified fraction of Poloxamer 407 with contrast,
and LeGootm is the same RTP with no contrast added. It has
been used for cardiac and vascular cases using direct intra-
arterial injection.7–11 Originally introduced to facilitate off-pump
coronary revascularization, it is now approved for human use in
cardiac and vascular application in Europe and is currently
before the Food and Drug Administration (FDA). Remarkably,
in these human cardiac trials, with special emphasis on the
detection of downstream myocardial injury, none was found.
Similarly, attempts to define local endothelial damage have
found none.9,11
In the present study, we have demonstrated that large portal
venous vessels can be temporarily occluded to allow for relatively
bloodless liver resection. Facilitating hepatic resection by blood
flow interruption becomes of significance in facilitating mini-
mally invasive or robotic techniques. However, blood flow inter-
ruption in the liver may have wider implications in the fields of
ablative therapies for liver masses and for chemotherapy and gene
therapy.12,13 Blood flow interruption to enhance ablative therapies
for liver tumours has been advocated but hindered by the absence
of a safe and simple means of providing it.14 Blood flow acts as a
heat sink for thermal ablations, requiring considerably more
energy transfer into the patient while defocusing the energy from
the targeted tissue. Many authors have attempted different
modalities to obtain inflow interruption with varying degrees of
Figure 4 Liver section at the cut margin, hematoxylin and eosin
(H&E) stain, 20¥. No pathological features from Lumagel instillation.
Note normal portal venous branch (Arrow)
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success. Similarly, during the administration of chemotherapeutic
agents, Lumagel can interrupt flow to uninvolved tissue thereby
concentrating the agents exactly on the targeted neoplasm. In this
application, as tumours are typically perfused only by hepatic
arterial flow, portal vein cannulation is probably unnecessary.
Finally, the benefit of interrupting hepatic flow using hepatic vein
occlusion has been shown, in which the ‘high-pressure’ occlusion
led to greatly increased accumulation of gene fragments in gene
transfer experiments.15,16 For the same reason, it is possible that
chemotherapeutic agents may accumulate in a greater concentra-
tion if the hepatic vein rather than the hepatic artery is used for
inducing interrupted flow. While this study did not address
hepatic vein plugging with Lumagel, this application is the ‘trivial’
case which would be far simpler than the complex plug deposition
achieved in the present study. Additional studies will be per-
formed to determine if complete vascular isolation of the liver can
be achieved with retrograde placement of a Lumagel in outflow
vessels.
The present study has shown that Lumagel may be used to
obtain temporary, reversible and atraumatic blood flow interrup-
tion to targeted portions of liver tissue, especially in larger com-
pliant venous branches while allowing uninterrupted portal flow
to uninvolved portions of the liver. In our experience, software-
assisted, 3-D CT angiography proved to be an invaluable tool for
surgical and radiographical planning in selecting the exact site for
intraluminal occlusion of the portal system. No discernable tox-
icity or pathological effect was observed in our survival experi-
ments. Especially important, plug dissolution did not cause
pulmonary emboli or any lasting haemodynamic effects.
It has been shown that blood-free liver resection using Lumagel
to occlude both the hepatic artery and the feeding branch of the
portal vein is feasible without adverse effects on survival and
organ pathology, in the swine model. However, the demonstrated
benefit at present is restricted to resection of the left lateral lobe,
thanks to its unique, long and easily accessible portal venous
branch. Work is underway on resection of other liver segments,
predicated on finding the appropriate venous branches for occlu-
sion. Further studies are required to define optimal sites for inflow
and outflow occlusion to facilitate hepatic resection. It is possible
that Lumagel may provide an added degree of safety during liver
resection during both open and laparoscopic cases and may aid
Resident and Fellow training by reducing blood in the operative
field. As fluoroscopic techniques improve, especially paired with
hybrid operating rooms where these techniques can be developed
with sophisticated equipment, temporary inflow and outflow
occlusion may actually increase the speed of hepatic resection as
minimal hilar dissection will be required. Finally, the application
of segmental or lobar inflow occlusion as it relates to ablation and
chemotherapy remains to be defined.
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